TALPHERA, INC. — Director's Dealing 2011

Mar 4, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2011-03-02

Reporting Person: Rosen Howard B (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-03-02	Common Stock	A	4394	$0.00	Acquired	4394	Direct

Footnotes

F1: Issued pursuant to the 2011 Equity Incentive Plan.